Clinical Reasoning: A young healthy woman with difficult-to-wean acute ventilator dependence
Citation Manager Formats
Make Comment
See Comments

Section 1
A 25-year-old woman with a history of occipital headaches and chronic smoking (2 pack-years) was found unconscious at home following a week of fatigue and drowsiness. She was intubated on-scene and admitted to the medical intensive care unit (ICU) for hypercapnic respiratory failure. CT scan of the chest revealed bibasilar opacities, leading to empiric treatment of pneumonia despite absence of fever and cough. Pulmonary opacities and mental status improved with treatment, but the patient failed multiple attempts to wean from ventilation before ultimate extubation. The patient then experienced sleep apnea as witnessed by hospital staff and remained persistently hypercapnic, requiring biphasic positive airway pressure (BiPAP) support. Bedside ultrasound revealed severe bidiaphragmatic weakness, prompting neurologic consultation for apparent neuromuscular respiratory failure. On examination, cranial nerves were intact. The patient had normal muscle tone, 4/5 strength in the right deltoid and right intrinsic hand muscles, no fatigable oculobulbar weakness, diffuse hyperreflexia (3/4 in bilateral brachioradialis, biceps, and triceps, 4/4 in both patellars, with 5–6 beats of clonus in both ankles), and bilateral Babinski sign. The patient had no cerebellar signs.
Questions for consideration:
Where should the lesion be localized?
What is the differential diagnosis of neuromuscular respiratory failure?
Section 2
Lesions in neuromuscular disorders that can affect respiratory function can be localized to the cervicomedullary junction, anterior horn cells of the cervicothoracic cord, multiple nerve roots, the brachial plexus, the bilateral phrenic nerves, peripheral nerves, the neuromuscular junction, or muscle.
The patient's signs (bilateral diaphragmatic weakness, possible central apnea, diffuse hyperreflexia, and weakness in the right C5, C8, and T1 myotomes) are concerning for a long-segment cervicomedullary junction lesion.
Intramedullary lesions of the craniocervical junction would have to be longstanding (slowly progressive or static) given the paucity of signs on examination compared to the expected extent of structural involvement (i.e., medulla to T1). Syringomyelia, neoplasms, and spinal arteriovenous malformations are top considerations.
Of the anterior horn cell diseases, amyotrophic lateral sclerosis is most common. Asymmetric limb or bulbar-onset weakness progressing in a regional fashion is typical and on examination reveals mixed upper (hyperreflexia as above) and lower (such as atrophy or fasciculations; absent in this patient) motor neuron signs. Polio-like syndrome secondary to certain viruses is characterized by acute flaccid paralysis of one or more limbs, possibly with pharyngeal or diaphragmatic involvement, during an acute febrile illness (unlike this case). For this lower motor neuron syndrome, hyporeflexia is expected. Respiratory failure in spinal muscular atrophy and Kennedy disease (X-linked spinobulbar muscular atrophy) is usually proportional to the degree of generalized weakness and is seen in patients with bulbar dysfunction. These diseases are associated with hyporeflexia and the latter with gynecomastia, testicular atrophy, and infertility.1
At the nerve root level, polyradiculopathy (acute in Guillain-Barré syndrome, chronic in chronic inflammatory demyelinating polyradiculoneuropathy, or other variants) can also result in diaphragmatic paresis. Importantly, these syndromes are associated with hyporeflexia or areflexia (rather than hyperreflexia as in this case), and respiratory failure is usually due to disease progression from typical initial symmetric sensorimotor symptoms in the extremities to eventually involve pharyngeal and respiratory muscles.1
Brachial plexitis (i.e., neuralgic amyotrophy or Parsonage-Turner syndrome) follows, which can reportedly cause bidiaphragmatic weakness. The characteristic clinical course begins with acute severe pain in the scapulohumeral region followed by progressive weakness, atrophy, and sensory loss in the arm and shoulder; diaphragmatic involvement is not uncommon. A variant with isolated phrenic neuropathy has been described.2
Distal to the plexus, bilateral phrenic neuropathies may occur with vasculitis, diabetes mellitus, chronic meningitides, and sarcoidosis, as part of multifocal motor neuropathy,3 or in association with critical illness polyneuropathy (CIP). Clinical context and temporal progression of symptoms can distinguish these etiologies.
Neuromuscular junction disorders (myasthenia gravis [MG], Lambert-Eaton myasthenic syndrome [LEMS], and botulism) are frequent suspects in such scenarios. MG classically features fatigable weakness, often presenting with ocular symptoms, and respiratory dysfunction occurring in patients with generalized myasthenia or prominent bulbar disease. LEMS is typically associated with areflexia and dysautonomia and is often paraneoplastic.
Muscle pathologies like dystrophinopathies, myotonic dystrophies, or myositis, or congenital, metabolic, or mitochondrial myopathies, can be associated with respiratory failure; again, respiratory muscle weakness is proportional to the degree of generalized weakness. Involvement of other organ systems (i.e., cardiac, smooth muscle, ocular) is expected.1 Adult-onset Pompe disease (acid maltase deficiency) presents as a proximal myopathy, similarly to a limb-girdle muscular dystrophy but with a preponderance towards the diaphragm and respiratory muscles. Electrographic myotonia in the paraspinals without clinical myotonia is a helpful distinguishing clue.
Neuromuscular weakness in the ICU with failure to wean from mechanical ventilation may be due to critical illness myopathy, CIP, or a combination thereof, occurring within 1–2 weeks of admission to the ICU. Depending on the degree of overlap, flaccid quadriparesis with atrophy, peripheral sensory loss, or hyporeflexia can exist. Cranial nerves are usually spared. Common triggers are sepsis, hyperglycemia, multiorgan failure, mechanical ventilation, and exposure to neuromuscular blocking agents or glucocorticoids.4
Section 3
The first priority is to evaluate cardiorespiratory etiologies for acute respiratory failure. If a neuromuscular etiology is suspected, a thorough history and examination is vital to localize the lesion. For signs predominant in upper motor neuron pathologies, brain and C-spine imaging are prioritized. A lower motor neuron pathology, depending on localization, could entail antibody testing, serologies, CSF studies, or EMG.
Cardiopulmonary workup of the patient was unremarkable. CT of the head on admission showed tonsillar ectopia but no hydrocephalus, mass lesions, or cerebral edema. Bidiaphragmatic paresis seen on bedside ultrasound was confirmed using a fluoroscopic sniff test. An empiric pyridostigmine trial minimally improved symptoms. Antibodies for myasthenia were negative.
Upon neurologic consultation for possible neuromuscular respiratory failure and central hypopnea, based on the discovery of florid hyperreflexia, an MRI of the brain was obtained, revealing a significant tonsillar ectopia of 18 mm below the foramen magnum and a dorsal cervicomedullary bump concerning for Chiari I malformation. Dedicated spine MRIs then captured an extensive C2-T6 syrinx (figure). Pulmonary function tests demonstrated restrictive disease pattern. Polysomnography revealed severe obstructive sleep apnea with an apnea–hypopnea index of 51. Due to this mixed pattern and her preference for nonsurgical management, the patient was discharged with nocturnal BiPAP support. At follow-up, her respiratory status remained stable, but she had worsening right hemiparesis with sensory ataxia and required a walker for ambulation. She is now reconsidering surgical options.
(A) Sagittal T1 image from MRI of the brain demonstrates an 18-mm tonsillar ectopia, dorsal cervicomedullary bump, and syringomyelia concerning for Chiari I malformation. (B) Sagittal T2 view from MRI of the cervical spine demonstrates large intrathecal hyperintensity consistent with a syrinx, extending downward from the C2 level. The lower limit was not captured in the image. (C) Sagittal T2 view from MRI of the thoracic spine demonstrates large intrathecal hyperintensity consistent with a syrinx and extending up to the T6 level. (D) Axial T2 view of the cervical spine shows a markedly dilated central canal appearing as a prominent intrathecal hyperintensity, consistent with syringomyelia.
Questions for consideration:
What are the pathophysiologic mechanisms of respiratory failure in this case?
What are the considerations in the management of Chiari malformation–related sleep-disordered breathing?
Section 4
Respiratory failure in patients with Chiari malformations can be central, obstructive, or mixed.5 Dysfunction in central respiratory events is believed to result from compression of central respiratory centers, compression of cranial nerves IX and X, or changes in afferent nerves due to expansion of syringomyelia. The latter is illustrated by patients who may be asymptomatic until a minor respiratory infection quickly progresses to respiratory failure; this scenario may be due to dysfunctional afferents from peripheral chemoreceptors, preventing an appropriate respiratory center response to infection-related hypoxia. Obstructive respiratory changes may appear in the context of cranial nerve dysfunction (nerves IX, X, XI, and XII) due to compression that would facilitate upper airway collapse.
With Chiari I malformations, respiratory depression can occur as a postoperative complication. Respiratory failure due to Chiari I malformation with or without syringomyelia is rare but has been reported.6 Fish et al.7 reported 2 patients with Chiari I malformations without syringomyelia who had brainstem compression–related central hypoventilation. Bullock et al.8 reported 2 patients with Chiari I malformations and syringomyelia who originally presented with acute respiratory failure; both had diaphragm dysfunction on radiography, and respiration improved following posterior fossa decompression.
Chiari-associated respiratory failure presents in several variations. It is important to distinguish the type of apneas (e.g., using polysomnography) in each patient to customize treatment.
Ferré Masó et al.9 reviewed sleep disorders in patients with Chiari I malformations and inferred the following approach based on 22 prior studies regarding response to surgical intervention. Posterior fossa decompression mainly improves central respiratory parameters, but results for the effect on obstructive apnea have been mixed (no change, partial improvement, or complete resolution). It was thus proposed that patients with predominantly obstructive apnea may be conservatively managed with noninvasive positive pressure ventilation, but those with central hypoventilation would require posterior fossa decompression.
Recurrent respiratory failure despite surgical decompression has been reported between 2 and 5 years posttreatment; patients must be followed with a high index of suspicion for recurrence. Repeating polysomnography when indicated is beneficial, and some argue that this could detect subclinical sleep-disordered breathing, allowing for early intervention to prevent associated mortality and morbidity.10
Chiari I malformation is a treatable condition that must be considered in the diagnostic evaluation of unexplained respiratory failure in a relatively healthy patient. Conversely, routine pulmonary function tests should be considered in these patients given the risk of progressive worsening or sudden deterioration of respiratory function and death.
Study funding
No targeted funding reported.
Disclosure
The authors report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.
Acknowledgment
The authors thank Omer Suhaib, MD, INTEGRIS Neurology at Baptist Medical Center, Oklahoma City, for manuscript review; and Jennifer Dennis-Wall, PhD, Owner, Sensical Science LLC, for editing the manuscript for nonintellectual content.
Appendix Authors

Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- © 2020 American Academy of Neurology
References
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- Dauvilliers Y,
- Stal V,
- Abril B, et al
- 6.↵
- 7.↵
- Fish DR,
- Howard RS,
- Wiles CM,
- Simon L
- 8.↵
- Bullock R,
- Todd NV,
- Easton J,
- Hadley D
- 9.↵
- Ferré Masó A,
- Poca MA,
- de la Calzada MD,
- Solana E,
- Romero Tomás O,
- Sahuquillo J
- 10.↵
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Diagnosis and progression of ALSHiroshi Mitsumoto et al.Neurology, April 01, 1997 -
Article
Neurofilament markers for ALS correlate with extent of upper and lower motor neuron diseaseKoen Poesen, Maxim De Schaepdryver, Beatrice Stubendorff et al.Neurology, May 12, 2017 -
Articles
The natural history of primary lateral sclerosisP. H. Gordon, B. Cheng, I. B. Katz et al.Neurology, March 13, 2006 -
Articles
Toward earlier diagnosis of amyotrophic lateral sclerosisRevised criteriaM. A. Ross, R. G. Miller, L. Berchert et al.Neurology, March 01, 1998